Cullinan Therapeutics, Inc. (CGEM) › Shareholders' EquityCullinan Therapeutics, Inc. (CGEM) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2019: $97.00M2020: $199.01M2021: $424.97M2022: $535.03M2023: $453.70M2024: $590.33M2025: $408.73M$408.73M2019Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$408.73M-30.8%2024$590.33M+30.1%2023$453.70M-15.2%2022$535.03M+25.9%2021$424.97M+113.5%2020$199.01M+105.2%2019$97.00M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share